An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models

Lars Arendt-Nielsen; Guang-Liang Jiang; Ronald DeGryse; Catherine C. Turkel

doi:10.1016/j.toxicon.2014.11.011

An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models

Lars Arendt-Nielsen, Guang-Liang Jiang, Ronald DeGryse, Catherine C. Turkel

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Toxicon
Volume	93
Issue number	Suppl.
Pages (from-to)	S4
ISSN	0041-0101
DOIs	https://doi.org/10.1016/j.toxicon.2014.11.011
Publication status	Published - Jan 2015
Event	TOXINS 2015: : Basic Science and Clinical Aspects of Botuli-num and Other Neurotoxins - Lisbon, Portugal Duration: 14 Jan 2015 → 17 Jan 2015

Conference

Conference	TOXINS 2015
Country/Territory	Portugal
City	Lisbon
Period	14/01/2015 → 17/01/2015

Access to Document

10.1016/j.toxicon.2014.11.011

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Arendt-Nielsen, L., Jiang, G-L., DeGryse, R., & Turkel, C. C. (2015). An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models. Toxicon, 93(Suppl.), S4. https://doi.org/10.1016/j.toxicon.2014.11.011

Arendt-Nielsen, Lars ; Jiang, Guang-Liang ; DeGryse, Ronald et al. / An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain : results from experimental pain models. In: Toxicon. 2015 ; Vol. 93, No. Suppl. pp. S4.

@article{752efa5f627a463681dabedb3d810983,

title = "An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models",

author = "Lars Arendt-Nielsen and Guang-Liang Jiang and Ronald DeGryse and Turkel, {Catherine C.}",

year = "2015",

month = jan,

doi = "10.1016/j.toxicon.2014.11.011",

language = "English",

volume = "93",

pages = "S4",

journal = "Toxicon",

issn = "0041-0101",

publisher = "Pergamon Press",

number = "Suppl.",

note = "TOXINS 2015 : : Basic Science and Clinical Aspects of Botuli-num and Other Neurotoxins ; Conference date: 14-01-2015 Through 17-01-2015",

}

Arendt-Nielsen, L, Jiang, G-L, DeGryse, R & Turkel, CC 2015, 'An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models', Toxicon, vol. 93, no. Suppl., pp. S4. https://doi.org/10.1016/j.toxicon.2014.11.011

An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models. / Arendt-Nielsen, Lars; Jiang, Guang-Liang; DeGryse, Ronald et al.
In: Toxicon, Vol. 93, No. Suppl., 01.2015, p. S4.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain

T2 - TOXINS 2015

AU - Arendt-Nielsen, Lars

AU - Jiang, Guang-Liang

AU - DeGryse, Ronald

AU - Turkel, Catherine C.

PY - 2015/1

Y1 - 2015/1

U2 - 10.1016/j.toxicon.2014.11.011

DO - 10.1016/j.toxicon.2014.11.011

M3 - Conference abstract in journal

SN - 0041-0101

VL - 93

SP - S4

JO - Toxicon

JF - Toxicon

IS - Suppl.

Y2 - 14 January 2015 through 17 January 2015

ER -

Arendt-Nielsen L, Jiang G-L, DeGryse R, Turkel CC. An exploratory, single-center, double-blind, randomized, placebo-controlled, parallel-group, 16-week study of the efficacy and safety of intra-articular onabotulinumtoxinA (OnabotA, 200 U) as treatment for osteoarthritis knee pain: results from experimental pain models. Toxicon. 2015 Jan;93(Suppl.):S4. doi: 10.1016/j.toxicon.2014.11.011